Halaman 2 - Kordoma Dokter Terbaik - TOP-53 dokter

Memimpin Departemen Lesi Tulang Metastastik di Ichilov Medical Center, yang berfokus secara khusus pada kanker tulang kompleks seperti kordoma.

• Ahli bedah ortopedi yang berspesialisasi dalam ortopedi onkologi
• Profesor di Fakultas Kedokteran Universitas Tel Aviv
• Menempuh pendidikan di Universitas Ibrani Yerusalem
• Menjalani magang klinis di Amerika Serikat
• Dokter senior di pusat ortopedi onkologi Israel

Lektor Kepala di Universitas Kedokteran Wina dan Wakil Kepala Divisi Klinis Onkologi – salah satu pusat penelitian kanker terkemuka di Austria.

• Spesialisasi selama lebih dari dua dekade dalam onkologi medis dan penyakit dalam
• Diakui secara internasional atas keahlian dalam terapi target tumor padat
• Fokus pada pengobatan kanker personal dan perawatan berbasis biomarker
• Berkontribusi pada penelitian translasi dan merancang strategi perawatan presisi baru
• Konsultan senior untuk terapi kanker sistemik individual di Wiener Privatklinik

Associate Professor Dr. Yusuf Acikgoz membawa keahlian internasional dari Ohio State University ke Rumah Sakit Universitas Lokman Hekim Ankara.

• Spesialisasi dalam Onkologi Medis dengan fokus pada uji klinis
• Berpartisipasi dalam studi Fase III seperti CheckMate-649 dan Fortitude-101
• Anggota American Society of Clinical Oncology (ASCO)
• Tersertifikasi dalam Praktik Klinis yang Baik dan Perlindungan Subjek Manusia

Profesor Keil berspesialisasi dalam radiologi intervensi, melakukan tindakan medis kompleks menggunakan teknik pencitraan canggih di Pusat Medis di Solingen.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Ahli dalam prosedur yang dipandu MRI, CT, dan ultrasonografi
• Mantan dokter terkemuka di Rumah Sakit Universitas Aachen
• Kepala Dokter di Rumah Sakit Akademik Solingen sejak 2022

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Alemdar berspesialisasi dalam onkologi medis di Kompleks Rumah Sakit Medical Park Antalya, dengan pelatihan ekstensif dalam penyakit dalam dan onkologi.

• Tersertifikasi dalam onkologi medis sejak 2018
• Pengalaman medis lebih dari 15 tahun di berbagai rumah sakit
• Pelatihan khusus di Fakultas Kedokteran Universitas Akdeniz
• Bekerja dengan pendekatan multidisiplin untuk perawatan kanker yang komprehensif

dr. Nail Paksoy menghadirkan keahlian khusus di bidang onkologi, dengan fokus pada kasus-kasus kompleks di Rumah Sakit Medipol Bahçelievler.

• Tersertifikasi dalam Onkologi Medis oleh ESMO
• Menerbitkan berbagai studi tentang kanker langka dan pengobatan inovatif
• Berpartisipasi aktif dalam uji klinis internasional untuk onkologi
• Associate Professor di Universitas Medipol Istanbul

Lebih dari 30 tahun pengalaman spesialisasi dalam viroterapi – salah satu bidang terbaru dalam imunologi – di Klinik Pallas.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Klinis Universitas Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Ahli dalam perawatan imunologis yang dapat disesuaikan dengan kondisi tertentu

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Spesialisasi dalam onkologi radiasi dengan pelatihan dari Universitas Marmara, yang terkenal dengan program medisnya yang ketat.

• Terlatih di Departemen Onkologi Radiasi Universitas Marmara
• Menyelesaikan studi sarjana kedokteran di Universitas Marmara
• Pendidikan mencakup pengalaman internasional dari Azerbaijan

Dr. Topcu membawa keahlian internasional dari MD Anderson dan Sunnybrook Odette Cancer Center ke Rumah Sakit Universitas Biruni.

• Spesialisasi dalam kanker langka termasuk kordoma dan sarkoma
• Anggota ESMO dan ASCO – standar onkologi global
• Pelatihan di lembaga terkemuka di AS, Kanada, dan Turki
• Menangani berbagai jenis kanker dengan kasus yang kompleks

Prof. Filippini spesialis dalam pengobatan bedah tumor stadium lanjut lokal, dengan pelatihan di Memorial Sloan Kettering Cancer Center dan City of Hope Oncology Center.

• Lebih dari 40 tahun pengalaman dalam bedah onkologi
• Pakar dalam teknik invasif minimal, laparoskopi, dan robotik
• Penulis lebih dari 100 publikasi ilmiah dan dua monograf
• Profesor di Universitas Chieti sejak 1990-an